Loading…
AngioDynamics, Inc. is projected to rise to $18.20 by 2027, a +42% move from its current price of $12.79. ANGO is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/11/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $12.56 | $12.80 | $13.05 | +0.10% |
| Jul 14 | $12.48 | $12.82 | $13.16 | +0.20% |
| Jul 15 | $12.42 | $12.83 | $13.25 | +0.29% |
| Jul 16 | $12.37 | $12.84 | $13.33 | +0.39% |
| Jul 17 | $12.32 | $12.85 | $13.40 | +0.49% |
| Jul 18 | $12.29 | $12.87 | $13.47 | +0.59% |
| Jul 19 | $12.25 | $12.88 | $13.53 | +0.69% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $12.25 | $12.88 | $13.53 | +0.69% |
| Week 2 | $12.09 | $12.97 | $13.91 | +1.38% |
| Week 3 | $11.98 | $13.06 | $14.23 | +2.07% |
| Week 4 | $11.90 | $13.15 | $14.52 | +2.78% |
| Week 5 | $11.84 | $13.24 | $14.79 | +3.48% |
| Week 6 | $11.80 | $13.33 | $15.05 | +4.19% |
| Week 7 | $11.76 | $13.42 | $15.30 | +4.91% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
AngioDynamics, Inc. is a healthcare company that designs, manufactures, and sells medical, surgical, and diagnostic devices for use in treating peripheral vascular disease, and oncology and surgical settings in the United States and internationally. It offers Auryon Atherectomy system that delivers an optimized wavelength and short pulse width to remove lesions while preserving vessel wall endothelium.
The thrombus management portfolio includes AlphaVac mechanical thrombectomy system, thrombolytic catheters that are used to dissolve blood clots, AngioVac venous drainage cannula and extracorporeal circuit for use in extracorporeal circulatory support procedures, and NanoKnife IRE Ablation System, an alternative to traditional thermal ablation for soft tissue. It also provides peripheral products, including angiographic catheters, diagnostic and interventional guidewires, and coaxial micro-introducer kits for use in peripheral diagnostic and interventional procedures, as well as abscession drainage catheters, micro-access kits, VenaCure EVLT system, and Solero Microwave Tissue Ablation System. AngioDynamics was founded in 1988 and is headquartered in Latham, New York.
AngioDynamics, Inc. (ANGO) operates in the healthcare sector, offering a range of medical devices for vascular, oncologic, and surgical applications across the U.S. and internationally.
The company trades with a current price of $13.66 and a market cap of $564.42M, and it holds a relatively low market-rank position (2955). The longer-term outlook is bullish, with a year-by-year forecast showing rising average prices from 2026 through 2050, including a notable expansion in later years.
A major floor 24.2% below — a decisive break under it would weaken the trend.
The nearest floor, 14.7% below — buyers have tended to step in here.
The nearest ceiling, 6.8% above — a clean break opens room to run.
A major ceiling 18.9% above — clearing it would confirm fresh momentum.
Key ANGO support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of ANGO market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $12.91 | Sell | $12.90 | Sell |
| MA 10 | $13.03 | Sell | $12.90 | Sell |
| MA 20 | $12.70 | Buy | $12.69 | Buy |
| MA 50 | $11.90 | Buy | $12.11 | Buy |
| MA 100 | $11.37 | Buy | $11.70 | Buy |
| MA 200 | $11.56 | Buy | $11.29 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 55.01 | Neutral |
| Stoch RSI (14) | 0.00 | Buy |
| CCI (20) | 13.60 | Neutral |
| Williams %R (14) | -67.44 | Info |
| MACD (12,26,9) | -0.06 | Sell |
| ROC (12) | 3.40 | Buy |
| Bollinger %B (20,2) | 0.55 | Neutral |
| Stochastic %K (14) | 32.56 | Neutral |
| TRIX (15) | 0.47 | Buy |
| Awesome (5,34) | 0.61 | Buy |
| Ultimate (7,14,28) | 46.43 | Neutral |
| Momentum (10) | -0.87 | Sell |
| Aroon Osc (25) | 60.00 | Buy |
| Hull MA (9) | 12.82 | Sell |
| ADX (14) | 20.03 | Buy |
| ATR (14) | 0.20 | Info |
In the near term, the technical picture shows bullish momentum with RSI14 at 70. The stock trades above both the SMA50 ($11.47) and SMA200 ($11.45), suggesting positive trend support.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $9.70 | $12.79 | $18.10 | 0% | Neutral | |
| $14.90 | $18.20 | $23.23 | +42% | Bullish | |
| $18.00 | $22.39 | $29.36 | +75% | Bullish | |
| $21.16 | $26.73 | $35.80 | +109% | Bullish | |
| $22.69 | $29.05 | $39.60 | +127% | Bullish | |
| $24.43 | $31.66 | $43.84 | +148% | Bullish | |
| $26.64 | $34.91 | $49.03 | +173% | Bullish | |
| $30.83 | $40.83 | $58.08 | +219% | Bullish | |
| $37.14 | $49.67 | $71.50 | +288% | Bullish | |
| $40.91 | $55.23 | $80.40 | +332% | Bullish | |
| $57.10 | $80.40 | $122.64 | +529% | Bullish | |
| $127.78 | $192.98 | $315.54 | +14.1x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $9.70 | $12.79 | $15.15 | +0.00% |
| August 2026 | $11.31 | $13.24 | $15.83 | +3.49% |
| September 2026 | $11.89 | $13.98 | $16.86 | +5.64% |
| October 2026 | $12.09 | $14.28 | $17.32 | +2.11% |
| November 2026 | $12.08 | $14.31 | $17.46 | +0.23% |
| December 2026 | $12.42 | $14.76 | $18.10 | +3.15% |
Click any year to see its month-by-month ANGO forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
AngioDynamics, Inc.'s 2026 outlook centres on $12.79, within a $9.70 to $18.10 range. That marks a 0% change versus current levels. Price action looks broadly range-bound.
By 2027, ANGO could reach as high as $23.23, with a base case around $18.20 and support toward $14.90 — roughly +42% from $12.79. Buyers look set to stay in control over this stretch.
Expect ANGO to range from $18.00 to $29.36 through 2028. The $22.39 average target implies a +75% move from current prices. That is up +23% on the projected 2027 average. Momentum favours further upside here.
The ANGO price prediction for 2029 points to an average of $26.73 (low $21.16, high $35.80) — a potential gain of +109% on today's $12.79. Buyers look set to stay in control over this stretch.
In 2030, ANGO is projected to trade between $22.69 and $39.60, averaging $29.05 — a potential gain of +127% from today's $12.79. That is up +9% on the projected 2029 average. Momentum favours further upside here.
AngioDynamics, Inc.'s 2031 outlook centres on $31.66, within a $24.43 to $43.84 range. That is up +9% on the projected 2030 average. That marks a +148% change versus current levels. Buyers look set to stay in control over this stretch.
By 2032, ANGO could reach as high as $49.03, with a base case around $34.91 and support toward $26.64 — roughly +173% from $12.79. Momentum favours further upside here.
Expect ANGO to range from $30.83 to $58.08 through 2033. The $40.83 average target implies a +219% move from current prices. That is up +17% on the projected 2032 average. Buyers look set to stay in control over this stretch.
The ANGO price prediction for 2034 points to an average of $49.67 (low $37.14, high $71.50) — a potential gain of +288% on today's $12.79. Momentum favours further upside here.
In 2035, ANGO is projected to trade between $40.91 and $80.40, averaging $55.23 — a potential gain of +332% from today's $12.79. That is up +11% on the projected 2034 average. Buyers look set to stay in control over this stretch.
AngioDynamics, Inc.'s 2040 outlook centres on $80.40, within a $57.10 to $122.64 range. That is up +46% on the projected 2035 average. That marks a +529% change versus current levels. Momentum favours further upside here.
By 2050, ANGO could reach as high as $315.54, with a base case around $192.98 and support toward $127.78 — roughly +14.1x from $12.79. Buyers look set to stay in control over this stretch.
Investing $1,000 in ANGO today (≈ 78.186083 ANGO) could be worth
$15,088.3
+$14,088.3 (+1409%) by 2050 · US Dollar
Based on the average projected ANGO price of $192.98 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in ANGOwould be worth at today's price.
$1,000 invested in ANGO on Jul 10, 2025 (≈ 105.485237 ANGO) would be worth
$1,349.16
+$349.16 (+34.9%) today · 1.35× · US Dollar
Based on a ANGO entry price of $9.48 vs. today's $12.79.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $13.09 | $977.08 | -2.3% |
| 1 month ago | $12.28 | $1,041.53 | +4.2% |
| 3 months ago | $9.8 | $1,305.1 | +30.5% |
| 6 months ago | $10.18 | $1,256.39 | +25.6% |
| 1 year ago | $9.48 | $1,349.16 | +34.9% |
| All time (5.0y) ago | $27.44 | $466.11 | -53.4% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our ANGO forecast.
Our base-case forecast reaches $26.00 around 2029.
Implied market cap at $26.00: $1.07B
The multi-year forecast depicts a rising trajectory in average prices and strong upside potential. In 2026 the avg is $13.66 with a 0% ROI and neutral sentiment, while 2027 shows an avg of $20.33 with a 48.9% ROI and bullish sentiment. By 2028 the avg rises to $25.61 (87.5% ROI) and remains bullish, and 2029 reports an avg of $31.44 (130.2% ROI).
The 2030 forecast further strengthens to an avg of $33.47 with a 145% ROI and bullish sentiment. Beyond, 2040 projects an avg of $105.03 (668.9% ROI) and 2050 an avg of $257.22 (1783% ROI), both with bullish sentiment. These figures imply a sustained uptrend over the long term, though these are estimates and subject to uncertainty and market conditions.
The forecast highlights upside potential while acknowledging that actual results may differ from these projections.
Tap a question to reveal the answer.
The 2030 forecast shows an avg price of $33.47, with a min of $25.36, a max of $47.40, and a projected ROI of 145%. The sentiment is bullish.
The forecast turns bullish starting in 2027, with rising averages and increasing ROI, reaching 1783% by 2050. The 2026 figure is neutral with an avg of $13.66 and 0% ROI.
Yes. The 2033 max is $73.69 and the 2034 avg is $61.74, with higher potential implied in the 2034–2033 period, indicating a path above $50 in the horizon.
Current price is $13.66 and market cap is $564.42M.
For 2040, the avg is $105.03 with a max of $170.10 (ROI 668.9) and bullish sentiment; for 2050, the avg is $257.22 with a max of $452.00 (ROI 1783) and bullish sentiment.
AngioDynamics, Inc. Community Discussion
0Share your AngioDynamics, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.